Prophylactic Pegfilgrastim Reduces Febrile Neutropenia in Ramucirumab plus Docetaxel After Chemoimmunotherapy in Advanced NSCLC: Post Hoc Analysis from NEJ051

0
153
The effects of prophylactic pegfilgrastim on febrile neutropenia prevention, therapeutic efficacy, and prognosis after ramucirumab plus docetaxel were evaluated in patients with advanced NSCLC.
[Scientific Reports]
Full Article